Activation of proresolving macrophages in dorsal root ganglia attenuates persistent arthritis pain
Proceedings of the National Academy of Sciences · 18.03.2025 · 122 (11)
DOI: 10.1073/pnas.2416343122 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 10.03.2025. Verfasst von Silvia Oggero und 7 weiteren Autor:innen. Beteiligte Einrichtung: Sensory, Pain and Regeneration Centre, Institute of Psychiatry, Psychology and Neuroscience, Kings College London, Guys' Campus, London SE1 1UL, Unit…. Hauptthemen laut MEDLINE: Ganglia, Spinal, Macrophages, Pain, Macrophage Activation. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Versus Arthritis.
Abstract (Originalsprache)
Pain independent of disease activity is frequently reported by rheumatoid arthritis patients and remains undertreated. Preclinical evidence suggests that imbalance of neuroimmune proresolving interactions within dorsal root ganglia (DRG) rather than at the site of inflammation plays mechanistic roles in persistent arthritis pain. Here, we inhibited production of proresolving lipid mediators by silencing 12/15-lipoxygenase expression in CX3CR1 + monocyte/macrophages conditional knockout (cKO) mice. In an arthritis model, hind paw mechanical hypersensitivity is exacerbated in male and female cKO mice in association with DRG infiltration of neutrophils, which migrate in response to leukotriene B 4 released by macrophages through 5-lipoxygenase conversion of arachidonic acid provided by neuron-derived vesicles. Neutrophils apoptosis promotes primary macrophage efferocytosis which is defective in cKO macrophages. In wild-type (WT) and cKO mice, intrathecal injection of MerTK activating antibody, attenuates persistent hypersensitivity and polarizes DRG macrophages toward a proresolving phenotype with production of antinociceptive lipoxin A 4 . Thus, we delineate a neuron–macrophage–neutrophil bidirectional circuit that can be exploited to reduce persistent arthritis pain.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Sensory, Pain and Regeneration Centre, Institute of Psychiatry, Psychology and Neuroscience, Kings College London, Guys' Campus, London SE1 1UL, United Kingdom.
- William Harvey Research Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, London EC1M 6BQ, United Kingdom.
- Department of Pharmacology, University of Granada, Granada 18016, Spain.
- Institute of Ophthalmology, Faculty of Brain Sciences, University College London, London EC1V 9EL, United Kingdom.
- Pediatric Respiratory Medicine, Royal Brompton Hospital, Guy's and St Thomas' National Health System Foundation Trust, London SW3 6NP, United Kingdom.
ORCID-Profile: Silvia Oggero, Mathieu-Benoit Voisin, Miguel Á Huerta, Chiara Cecconello, Thomas Burgoyne, Mauro Perretti, Marzia Malcangio
Förderung
- Versus Arthritis
Zitieren
APA
Oggero, S., Voisin, M. B., Picco, F., Huerta, M. Á., Cecconello, C., Burgoyne, T., Perretti, M., & Malcangio, M. (2025). Activation of proresolving macrophages in dorsal root ganglia attenuates persistent arthritis pain. Proceedings of the National Academy of Sciences, 122(11). https://doi.org/10.1073/pnas.2416343122
Vancouver
Oggero S, Voisin MB, Picco F, Huerta MÁ, Cecconello C, Burgoyne T, et al. Activation of proresolving macrophages in dorsal root ganglia attenuates persistent arthritis pain. Proceedings of the National Academy of Sciences. 2025;122(11). doi:10.1073/pnas.2416343122
BibTeX
@article{Oggero2025,
author = {Oggero, Silvia and Voisin, Mathieu-Benoit and Picco, Francesca and Huerta, Miguel Á and Cecconello, Chiara and Burgoyne, Thomas and Perretti, Mauro and Malcangio, Marzia},
title = {Activation of proresolving macrophages in dorsal root ganglia attenuates persistent arthritis pain},
journal = {Proceedings of the National Academy of Sciences},
year = {2025},
volume = {122},
number = {11},
doi = {10.1073/pnas.2416343122}
}
EUVIMED